Equiplas® R (equine IgG and Rhodococcus equi antibody, equine origin) is for the treatment of failure of passive transfer (FPT) and/or as an aid in the management and control of respiratory disease associated with Rhodococcus equi.
The minimum IgG content is 2400 mg/dl
This product is intended for use in foals less than 6 months of age
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.